Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drugs in pregnancy].

A J Scheen1

  • 1Département de Médecine, CHU Sart Tilman, Liège 1.

Revue Medicale De Liege
|July 8, 1999
PubMed
Summary
This summary is machine-generated.

Prescribing medications during pregnancy is complex due to potential fetal risks, like those seen with thalidomide. Lack of data and emotional factors make drug decisions challenging for healthcare providers.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

Area of Science:

  • Pharmacology
  • Teratology
  • Obstetrics

Background:

  • The thalidomide tragedy highlighted the risks of drug-induced fetal malformations.
  • Prescribing medications to pregnant individuals presents significant challenges for healthcare professionals.

Observation:

  • The risk of drug-induced fetal abnormalities is a recognized concern for the public and medical community.
  • Factors contributing to prescribing difficulties include scientific data limitations and the sensitive nature of pregnancy.

Findings:

  • The complexity of drug safety in pregnancy requires careful consideration.
  • Limited robust scientific data complicates risk-benefit assessments for medications during gestation.

Implications:

  • Accurate and accessible information is crucial for safe prescribing practices in pregnant women.
  • Improved guidelines and research are needed to support healthcare providers in managing medications during pregnancy.